Wei Wang

Wei Wang is an experienced professional in the pharmaceutical industry, currently serving as Vice President of Production at Bachem since September 2020, where responsibilities include the manufacturing of peptides as active pharmaceutical ingredients (API) and drug candidates in compliance with cGMP regulations, along with the commercial production of PMO drug substances. Prior to this role, Wei Wang held multiple positions at CSBio Co., initially as Vice President of Development & Quality Control from February 2018 to September 2020, and earlier as Vice President of Research & Development and Director from February 2010 to February 2018, demonstrating a strong background in development, quality control, and research.